Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) Growth Rank : 1 (As of Apr. 29, 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hebei Changshan Biochemical Pharmaceutical Co Growth Rank?

Hebei Changshan Biochemical Pharmaceutical Co has the Growth Rank of 1.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Hebei Changshan Biochemical Pharmaceutical Co's Growth Rank

For the Biotechnology subindustry, Hebei Changshan Biochemical Pharmaceutical Co's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hebei Changshan Biochemical Pharmaceutical Co's Growth Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hebei Changshan Biochemical Pharmaceutical Co's Growth Rank distribution charts can be found below:

* The bar in red indicates where Hebei Changshan Biochemical Pharmaceutical Co's Growth Rank falls into.

Save Embed

;

Save Embed

;

Hebei Changshan Biochemical Pharmaceutical Co Growth Rank Related Terms

Thank you for viewing the detailed overview of Hebei Changshan Biochemical Pharmaceutical Co's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Hebei Changshan Biochemical Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

North of Yinchuan Street, Zhengding New District, Hebei, Shijiazhuang, CHN, 050800

Website

http://www.hbcsbio.com

Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.

Executives

Li Zhi Hua	Executives
Wang Jun	Executives
Ding Jian Wen	Directors, executives
Huang Guo Sheng	Executives
Gao Shu Hua	Directors, executives
Chen Xi	Director
Cai Hao	Executives
Ji Sheng Li	Directors, executives
Li Xin	Securities Affairs Representative
Zhang Wei	Secretary Dong
Liu Jian	Executives
Zhang Zhi Ying	Executives
Guo Yan Xing	Supervisors

Hebei Changshan Biochemical Pharmaceutical Co Headlines

No Headlines